Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I've already tried catching a falling knife with this share and my hand is suitably bloodied - I won't be adding more. The running commentary on the share price is not because I expect riches next week, far from it, it more reflects my deep shock at the seemingly endless rout. Yup, I better stop looking daily at this - into the dusty drawer it goes!
My understanding is that there is little confidence in the leadership and track record - TBD. Supply issues and price power - possible problems. Input costs need to be passed on but try doing that if you don't have pricing power or partly dependent on discretionary spend.
Tax loss selling will also kick in some time.
Good luck catching this knife.
Get the message, its a dog. Take off the roase tinted glasses and idea of riches by this time next week and its not worth the stress here. BRSC are not stupid from what I can see, follow the non-stupid.
I'm getting a buy quote under 30p - 29.80p to be precise - that's approaching the all-time lows of March 2020. Remarkable.
...decline. If there are any mug LTHs like me left, this share has not finished with us yet! Today's decline possibly caused by the trashing of the management and company at last night's Mello, per a poster on the other forum.
Big boy leaving in my opinion and dropping its small cap dogs to make the averages look better.
Can't blame them if you read up on the headwinds. Money is better allocated elsewhere.
Is it possible someone has been trying to drum up PI support to allow a better exit for someone else? I'm cynical.
They tipped Venture Life and Purplebricks, lol - kiss of death!
Vox Market's recent tips have been rubbish. Can't see any news to explain today's 8% decline. A major holder selling?
https://podcasts.apple.com/gb/podcast/the-vox-markets-podcast/id1569138869VLG called out as a value play
Put it this way. A period is coming where cash will be king again so sell your dogs early and get a watchlist of decent companies ready. It makes sense and how can this turn around when there's tax loss selling in the run up to the end of the tax year? Blackrock are not idiots.
Not bottomed yet imho and volatility galore. As for ST in IC. We'll, look at PTRO vs forecast. Thnk for yourself.
They have sold down and if you read the last portfolio update and think about VLG vs the others in there you can see why.
How quickly can VLG pass on price increases and not see a demand drop?
Pricing power, good luck.
Anyway, the purchases didn't move the dial this morning so perhaps the market does indeed regard them as token. Disappointed.
Don't know about all of that. Within the statutory constraints, Director's are allowed to sell when they think the price is high, such as in Nov 2020 shortly after the successful mouthwash test, and buy back in when they think it's low, such as now. After all, they are in the business of enriching themselves. As I see it, a £100K+ purchase of shares is not immaterial, esp just now with omicron.
ALSO HE TIPPED IOMART AT 2.80, CURRENTY 1.40
Whom do the directors want to make fools of?
PIs or Simon Thompson from Investors Chronicle who ramped this company as much as he could over the summer...)
So, each of 3 directors just bough 100,000 shares each for 35p, investing about £35K each.
These same 3 directors sold in November 2020:
Director A) 2,752,751 shares (including Ordinary Shares arising on exercise of EMI Options as detailed below) to be sold at a price of £0.90 per Ordinary Share (Options: 705,700 options have been exercised at a price of £0.45 per Ordinary Share and 162,187 options have been exercised at a price of £0.41 per Ordinary Share.)
Director B) 1,877,864 shares to be sold to be sold at a price of £0.90 per Ordinary Share (including Ordinary Shares arising on exercise of EMI Options as below) (Options: 705,700 options have been exercised at a price of £0.45 per Ordinary Share and 162,187 options have been exercised at a price of £0.41 per Ordinary Share.)
- Director C) 3,542,729 shares to be sold will be sold at a price of £0.90 per Ordinary Share.
In short 1 year ago each of them sold shares from which received over £2 million (director A), over £1.5 million (director B) and over £3M (director C)
Do they think that reinvesting £35K each of the million+ they made on selling shares last year is going to convince anyone that this company is viable?
ABSOLUTELY NOT.
This company is over in its current form. In my eyes the directors have no credibility left. (It would be interesting to know which is the Chinese company (and who wns it) which was used to ramp up the share price during Covid. The products were sent there, but they have not paid them in full.)
VLG is just another dubious AIM company...
...reported to the market at 16.22 hours. This is a very, very positive sign!
Maybe it will come good, but I don't think we should be investing in this company on the basis of the mouthwash. As for this Simon Thompson fellow, I was influenced by his heavy ramping and am now well under water. He talks a good game but not so good on the results.
Sadly the developing world can’t afford even the cheap mounthrinses produced in Italy. They cost too much to transport and after a few bottles the cost is more than a vaccine jab.
I suspect that it is too difficult to measure the effects and make. Important findings and the best result possible is promising but more research is needed.
The board through its acquisitions is rebuilding the company with higher margin products….it won’t be long before some are calling for a break up or sale to PE.
Thanks Jon, that is useful information. Colgate seem to have been investigating around the same time, or a little after, and got the same result. So, yes, not unique.
They also seem to look on it as a means to lower the likelihood of passing the bug on to others, while my dreamy hope is that if the primary infection is in the throat then gargling at the right time might knock it out completely, or at least knock out so much that it delays the progress so much that the immune system gets time to man the defences and sort it. 2 up by half time: far less likely to progress to serious infection. Plus it acts as a free booster jab.
While not unique it would mean that they have in full production and with all permits and systems in place, and export routes across the world, something cheap that is a major contributor against the disease, and is variant agnostic. Especially great for those many countries that aren't able to get their hands on jabs, and those in rich countries unwilling to have them.
https://www.facebook.com/dinosandcomics/photos/a.353272316532075/421913583001281
I'm not sure if VLG have anything unique here. Colgate seemed to be getting similar results:
https://www.nature.com/articles/s41415-020-2476-8
Interesting the space they give to what nobody seems interested in:
"The Company continues to await the publication of the peer-reviewed in vivo study carried out by Cardiff University, which was completed in April this year. Whilst the Board is disappointed that this has taken longer than expected to publish, and does acknowledge that the timing is outside the control of Cardiff University, it is hopeful the final publication will be available soon. Further, the Company notes the recent announcement made by Salisbury Hospital regarding specific mouth care guidance for patients with Covid-19. As well as regular toothbrushing, the guidance also suggests that both Dentyl Dual Action and Dentyl Fresh Protect should be used. The Company understands this guidance was based on research conducted by Doctors at Salisbury Hospital, as well as the in-vitro (lab based) results widely published by Cardiff University in November 2020."
First I'm just relieved that they mention it at all. If the results were bad and being quietly buried they wouldn't. Second, they mention their disappointment, and point the finger of blame - sort of. They're publicly kicking some hidden someone up the proverbial. If the truth is it does work that person/s will have many lives on their hands, and now has an interest in it not working: but the figures will be the figures and if you twisted them too far in a bad direction you could turn a nightmare into an utter disaster. The best thing for them is to get them out soon. I would be hopeful for this month.
Remember the in vitro results from 21st October last year:
"Today, the Company provides an update on the recently published[1] in-vitro results from a separate, independent laboratory study undertaken at Cardiff University by Dr Richard Stanton and his colleagues.
In their published in-vitro[2] study, scientists at Cardiff University concluded that Venture Life's two CPC based mouthwashes eradicated the SARS-CoV-2 (COVID-19) virus completely (>5log reduction, equivalent to 99.999%) within a 30 second exposure. The virus was supplied by Public Health England, unlike other similar studies reported in the media, which have not used the relevant COVID-19 virus, but a related strain of it.
Cardiff University went on to state that the 'exact formulation is also important'. Whilst the CPC technology in Venture Life's mouthwash proved highly effective in the in-vitro study, they also tested a third mouthwash, which also contained both CPC and another ingredient, yet this proved ineffective."
99.999% reduction with a 30 second in vitro exposure.
Yes, I know: throat, not nose (use Taffix), and lung (see SNG001 from Synairgen) - but gaining the body vital TIME. And the Salisbury docs agree.
Still gargling. Still well. And tripled my holding.
It'll be interesting to see ST's update in Investor's Chronicle when he's back in the New Year. Last updates on this were:
10/08/2021 (92p): Venture’s shares have doubled since I initiated coverage, at 45p, in my May 2019 Alpha Report, and offer 50 per cent potential upside to my 130p target price. Buy.
16/08/2021 (65p): In my view, there has been a massive overreaction to last week’s trading update – 2022 forecasts are in line with the expectations I outlined in last week’s article – and the share price fall is not only overdone, but is likely to prove a cracking buying opportunity. I am certainly not changing my 130p target price. Buy
Some of these tips seem to need some serious wealth warnings! 92p to 130p is 42% upside; currently it's down 62% from there - not great risk/reward. Loop-up was another dud.
At least the commercial property and mining tips are asset-backed and probably have some tailwinds behind them (recovery plays on NAV and commodity super-cycle).
Aquisitions?
SP needs to triple before any mention of an aquisition.